ADVFN ADVFN

Hot Features

Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Prescient Therapeutics Limited

Prescient Therapeutics Limited (PTX)

0.062
0.001
(1.64%)
終了 7月1日 3:00PM

Prescient Therapeutics Limited (PTX) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

主要統計と詳細

通貨
0.062
( 1.64% )
買値
0.062
売値
0.067
出来高
612,943
0.061 日の範囲 0.064
0.04 52 週間の範囲 0.125
時価総額
前日終値
0.061
始値
0.061
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
AUD 952,134
発行済株式数
1,051,514,543
配当利回り
PER
-6.18
1 株当たり利益 (EPS)
-0.01
歳入
4.27M
純利益
-8.86M

Prescient Therapeutics Limited について

Prescient Therapeutics Limited, a clinical stage oncology company, develops drugs for the treatment of haematological and solid cancers in Australia. Its lead drug candidate is PTX-100, a first in class targeted therapy which can disrupt the RAS family pathway by inhibiting the prenylation action of... Prescient Therapeutics Limited, a clinical stage oncology company, develops drugs for the treatment of haematological and solid cancers in Australia. Its lead drug candidate is PTX-100, a first in class targeted therapy which can disrupt the RAS family pathway by inhibiting the prenylation action of the enzyme GGT-1. The company was formerly known as Virax Holdings Limited and changed its name to Prescient Therapeutics Limited in December 2014. Prescient Therapeutics Limited was incorporated in 1986 and is based in Melbourne, Australia. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Melbourne, Australia
設立
1986
Prescient Therapeutics Limited is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker PTX. The last closing price for Prescient Therapeutics was AUD0.06. Over the last year, Prescient Therapeutics shares have traded in a share price range of AUD 0.04 to AUD 0.125.

Prescient Therapeutics currently has 1,051,514,543 shares in issue. The market capitalisation of Prescient Therapeutics is AUD65.19 million. Prescient Therapeutics has a price to earnings ratio (PE ratio) of -6.18.
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.004-6.060606060610.0660.0660.05715753740.06133058DE
4-0.015-19.48051948050.0770.0770.0578962350.06541906DE
120.012240.050.0880.0499493480.06368827DE
26-0.02-24.39024390240.0820.0960.04910689100.06694879DE
520.01634.78260869570.0460.1250.0413700360.0638166DE
156-0.017-21.51898734180.0790.1250.0379589780.05865886DE
260-0.143-69.7560975610.2050.3050.03711682730.12731103DE

PTX - Frequently Asked Questions (FAQ)

What is the current Prescient Therapeutics Limited share price?
The current share price of Prescient Therapeutics Limited is AUD 0.062
How many Prescient Therapeutics Limited shares are in issue?
Prescient Therapeutics Limited has 1,051,514,543 shares in issue
What is the market cap of Prescient Therapeutics Limited?
The market capitalisation of Prescient Therapeutics Limited is AUD 65.19M
What is the 1 year trading range for Prescient Therapeutics Limited share price?
Prescient Therapeutics Limited has traded in the range of AUD 0.04 to AUD 0.125 during the past year
What is the PE ratio of Prescient Therapeutics Limited?
The price to earnings ratio of Prescient Therapeutics Limited is -6.18
What is the cash to sales ratio of Prescient Therapeutics Limited?
The cash to sales ratio of Prescient Therapeutics Limited is 15.04
What is the registered address of Prescient Therapeutics Limited?
The registered address for Prescient Therapeutics Limited is Suite 2, Melbourne, Victoria, 3000
What is the Prescient Therapeutics Limited website address?
The website address for Prescient Therapeutics Limited is ptxtherapeutics.com
Which industry sector does Prescient Therapeutics Limited operate in?
Prescient Therapeutics Limited operates in the Biotechnology & Life Sciences sector

PTX 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock